Is Metastatic Staging Needed for All Patients with Synchronous Bilateral Breast Cancers?
Cancers · 19.12.2023 · 16 (1) · 17
DOI: 10.3390/cancers16010017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 19.12.2023. Verfasst von Geok Hoon Lim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Breast Department, KK Women's and Children's Hospital, Singapore 229899, Singapore. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Patients with bilateral breast cancers are uncommon and are associated with a poorer prognosis. While metastatic staging guidelines in patients with unilateral cancer were established, the indication of metastatic staging in patients with bilateral breast cancers is unclear. We aimed to determine which patients with synchronous bilateral breast cancers require metastatic staging at diagnosis. This is the first such reported study, to the best of our knowledge.
Methods
A retrospective review of newly diagnosed synchronous bilateral invasive breast cancer patients at our institution was performed. We excluded patients with malignant phyllodes or no metastatic staging. Patients’ demographics and pathological and staging results were analysed to determine the group of bilateral breast cancer patients who required metastatic staging.
Results
A total of 92 patients with synchronous bilateral invasive cancers were included. The mean age was 58 years old, and 64.1% had bilateral invasive ductal carcinoma. 23.9% had systemic metastasis. Nodal status was statistically significant for systemic metastasis on staging (p = 0.0081), with only three patients (3.3%) having negative nodal status and positive metastatic staging. These three patients, however, showed symptoms of distant metastasis. 92.3% of patients with negative nodes also had negative metastatic staging. Using negative nodal status as a guide avoided metastatic staging in 40.4% of all patients.
Conclusions
Negative nodal status was the most predictive factor for no systemic metastasis on staging in patients with synchronous bilateral invasive breast cancers. Hence, metastatic staging could be reserved for patients with symptoms of systemic metastasis and/or metastatic nodes. This finding could be validated in larger studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Breast Department, KK Women's and Children's Hospital, Singapore 229899, Singapore.
- Duke-NUS Medical School, Singapore 169857, Singapore.
- Division of Radiation Oncology, National Cancer Centre, Singapore 168583, Singapore.
ORCID-Profile: Geok Hoon Lim
Zitieren
APA
Lim, G. H., Hoo, J. X., Shin, Y. C., Choo, R. Z. T., Wong, F. Y., & Allen, J. C. (2023). Is Metastatic Staging Needed for All Patients with Synchronous Bilateral Breast Cancers?. Cancers, 16(1), 17. https://doi.org/10.3390/cancers16010017
Vancouver
Lim GH, Hoo JX, Shin YC, Choo RZT, Wong FY, Allen JC. Is Metastatic Staging Needed for All Patients with Synchronous Bilateral Breast Cancers?. Cancers. 2023;16(1):17. doi:10.3390/cancers16010017
BibTeX
@article{Lim2023,
author = {Lim, Geok Hoon and Hoo, Jing Xue and Shin, You Chan and Choo, Rachel Zhi Ting and Wong, Fuh Yong and Allen, John Carson},
title = {Is Metastatic Staging Needed for All Patients with Synchronous Bilateral Breast Cancers?},
journal = {Cancers},
year = {2023},
volume = {16},
number = {1},
pages = {17},
doi = {10.3390/cancers16010017}
}
EUVIMED